Related references
Note: Only part of the references are listed.Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023
Nuha A. ElSayed et al.
DIABETES CARE (2023)
Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2023
Nuha A. ElSayed et al.
DIABETES CARE (2023)
Interventions for Reversing Prediabetes: A Systematic Review and Meta-Analysis
Karla Galaviz et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2022)
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
Hong Sun et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2022)
Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study
Ronald B. Goldberg et al.
CIRCULATION (2022)
Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program
Leigh Perreault et al.
DIABETES CARE (2022)
What's preventing us from curbing the obesity crisis?
[Anonymous]
LANCET DIABETES & ENDOCRINOLOGY (2022)
Tirzepatide Once Weekly for the Treatment of Obesity
Ania M. Jastreboff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
HbA1c Performance in African Descent Populations in the United States With Normal Glucose Tolerance, Prediabetes, or Diabetes: A Scoping Review
Lakshay Khosla et al.
PREVENTING CHRONIC DISEASE (2021)
Risk of Progression to Diabetes Among Older Adults With Prediabetes
Mary R. Rooney et al.
JAMA INTERNAL MEDICINE (2021)
Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis
Unjali P. Gujral et al.
BMJ OPEN DIABETES RESEARCH & CARE (2021)
Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement
Karina W. Davidson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Trajectories of Body Weight and Fat Mass in Relation to Incident Prediabetes in a Biracial Cohort of Free-Living Adults
Nisreen Abu Al Hommos et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
Trends in Self-reported Prediabetes and Metformin Use in the USA: NHANES 2005-2014
Caroline Liu et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016
Linda J. Andes et al.
JAMA PEDIATRICS (2020)
Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial
Hertzel C. Gerstein et al.
DIABETES CARE (2020)
Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis
Xiaoyan Cai et al.
BMJ-British Medical Journal (2020)
Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
David M. Nathan et al.
DIABETES CARE (2019)
Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes
Kieren J. Mather et al.
DIABETES CARE (2019)
Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)
Leigh Perreault et al.
DIABETES CARE (2019)
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study
Qiuhong Gong et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014
Mohammed K. Ali et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Contributions of A1c, fasting plasma glucose, and 2-hour plasma glucose to prediabetes prevalence: NHANES 2011-2014
Andy Menke et al.
ANNALS OF EPIDEMIOLOGY (2018)
Prediabetes Is Associated With Structural Brain Abnormalities: The Maastricht Study
Marnix J. M. van Agtmaal et al.
DIABETES CARE (2018)
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
Bernd Richter et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Carel W. le Roux et al.
LANCET (2017)
Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study
Bethany Warren et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Insulin-sensitive and insulin-resistant obese and non-obese phenotypes: role in prediction of incident pre-diabetes in a longitudinal biracial cohort
Ibiye Owei et al.
BMJ OPEN DIABETES RESEARCH & CARE (2017)
Functional Brain Networks Are Altered in Type 2 Diabetes and Prediabetes: Signs for Compensation of Cognitive Decrements? The Maastricht Study
Frank C. G. van Bussel et al.
DIABETES (2016)
Diabetes and Prediabetes and Risk of Hospitalization: The Atherosclerosis Risk in Communities (ARIC) Study
Andrea L. C. Schneider et al.
DIABETES CARE (2016)
Prevalence of Diabetes in Adolescents Aged 12 to 19 Years in the United States, 2005-2014
Andy Menke et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014
Cynthia L. Ogden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW
Devjit Tripathy et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
The Effect of Lifestyle Intervention and Metformin on Preventing or Delaying Diabetes Among Women With and Without Gestational Diabetes: The Diabetes Prevention Program Outcomes Study 10-Year Follow-Up
V. R. Aroda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Relationship Between Insulin Resistance and β-Cell Dysfunction in Subphenotypes of Prediabetes and Type 2 Diabetes
Kristine Faerch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Xavier Pi-Sunyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study
David M. Nathan
LANCET DIABETES & ENDOCRINOLOGY (2015)
Trends in Prevalence and Control of Diabetes in the United States, 1988-1994 and 1999-2010
Elizabeth Selvin et al.
ANNALS OF INTERNAL MEDICINE (2014)
Regression From Prediabetes to Normal Glucose Regulation Is Associated With Reduction in Cardiovascular Risk: Results From the Diabetes Prevention Program Outcomes Study
Leigh Perreault et al.
DIABETES CARE (2014)
Lack of Racial Disparity in Incident Prediabetes and Glycemic Progression Among Black and White Offspring of Parents With Type 2 Diabetes: The Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC) Study
Samuel Dagogo-Jack et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Approaching Pre-diabetes
Leigh Perreault et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2014)
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study
Guangwei Li et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Secular Changes in US Prediabetes Prevalence Defined by Hemoglobin A1c and Fasting Plasma Glucose National Health and Nutrition Examination Surveys, 1999-2010
Kai McKeever Bullard et al.
DIABETES CARE (2013)
Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS)
J. Lindstrom et al.
DIABETOLOGIA (2013)
Family history of diabetes is associated with higher risk for prediabetes: a multicentre analysis from the German Center for Diabetes Research
Robert Wagner et al.
DIABETOLOGIA (2013)
Rate and risk predictors for development of self-reported type-2 diabetes mellitus over a 5-year period: the SHIELD study
H. W. Rodbard et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study
Leigh Perreault et al.
LANCET (2012)
Changes Over Time in Glycemic Control, Insulin Sensitivity, and β-Cell Function in Response to Low-Dose Metformin and Thiazolidinedione Combination Therapy in Patients With Impaired Glucose Tolerance
Ravi Retnakaran et al.
DIABETES CARE (2011)
Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study
Q. Gong et al.
DIABETOLOGIA (2011)
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
Ralph A. DeFronzo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Glucose-Independent, Black-White Differences in Hemoglobin A1c Levels
David C. Ziemer et al.
ANNALS OF INTERNAL MEDICINE (2010)
Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes
Laura C. Plantinga et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors The Insulin Resistance Atherosclerosis Study (IRAS)
Carlos Lorenzo et al.
DIABETES CARE (2010)
Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study
Bernard Zinman et al.
LANCET (2010)
Pitfalls in the use of HbA1c as a diagnostic test: the ethnic conundrum
Samuel Dagogo-Jack
NATURE REVIEWS ENDOCRINOLOGY (2010)
Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
John J. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial
Jolien de Jager et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
Ralph A. DeFronzo
DIABETES (2009)
International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Pioglitazone does not enhance the effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2)
A. Ramachandran et al.
DIABETOLOGIA (2009)
Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study
E. L. M. Barr et al.
DIABETOLOGIA (2009)
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
G. A. Bray et al.
LANCET (2009)
Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance
Ryuzo Kawamori et al.
LANCET (2009)
Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes?
Leigh Perreault et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions
Robert E. Ratner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study
Guangwei Li et al.
LANCET (2008)
Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program
William H. Herman et al.
DIABETES CARE (2007)
Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance - The Australian diabetes, obesity, and lifestyle study (AusDiab)
Elizabeth L. M. Barr et al.
CIRCULATION (2007)
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial
H. C. Gerstein et al.
LANCET (2006)
Effect of weight loss with lifestyle intervention on risk of diabetes
Richard F. Hamman et al.
DIABETES CARE (2006)
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program
Jose C. Florez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)
A Ramachandran et al.
DIABETOLOGIA (2006)
Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan
CP Wen et al.
DIABETES CARE (2005)
The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality - Data from the Baltimore Longitudinal Study of Aging with a critical review of the literature
JD Sorkin et al.
DIABETES CARE (2005)
Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males
K Kosaka et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin
T Nakagami
DIABETOLOGIA (2004)
XENical in the prevention of diabetes in obese subjects (XENDOS) study
JS Torgerson et al.
DIABETES CARE (2004)
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial
JL Chiasson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging
JB Meigs et al.
DIABETES (2003)
beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
AE Butler et al.
DIABETES (2003)
Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women
TA Buchanan et al.
DIABETES (2002)
Acarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trial
JL Chiasson et al.
LANCET (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
J Tuomilehto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Subclinical stales of glucose intolerance and risk of death in the US
SH Saydah et al.
DIABETES CARE (2001)
Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type a diabetes development
C Weyer et al.
DIABETES CARE (2001)
Share Paper
